What if a simple urine test could detect mental stress before it turns into depression? This study reveals that specific brain chemicals in your pee might be the key to spotting burnout early. Almost ten percent of people develop depression or anxiety during their lifetime, making early detection crucial.

Since high stress increases the risk of these disorders, we need to find ways to remove stress before it becomes a disease. The goal here is to create an objective test that quantifies stress in workers so they can fix it early. Current diagnosis relies on subjective doctor assessments, which makes it hard to catch pre-disease states.

While cortisol is a known stress marker, its levels fluctuate throughout the day, requiring strict timing for sampling. Urine offers a convenient, non-invasive alternative that can be collected easily outside of hospitals. Standard depression questionnaires often fail to spot mild stress in healthy people because they are designed for diagnosed patients.

Instead, the Brief Job Stress Questionnaire is better suited because it measures work environments and personal life factors. Figure one outlines the study design and target analytes. Part A illustrates that researchers collected serum, saliva, and urine samples from healthy volunteers who fasted overnight, alongside psychological assessments using the BJSQ and CES-D questionnaires.

Part B maps the metabolic pathways of six specific urinary neurotransmitters, including dopamine and serotonin, which were analyzed to understand their biological relationships within the participants. The researchers collected urine from one hundred healthy volunteers after they completed medical checks and the stress questionnaire.

Participants were split into high and low stress groups based on their total scores. They then used liquid chromatography-mass spectrometry to measure six specific urinary neurotransmitters. To ensure the questionnaire answers were honest, the authors compared them against a standard depression scale.

The results showed a strong correlation of point six nine, confirming the data was reliable. Figure 2 compares the new BJSQ tool against the established CES-D scale to validate its reliability. Panel A displays a scatter plot of total scores, showing a positive correlation between the two measures with a fitting curve and confidence intervals.

Meanwhile, Panel B illustrates how response distributions differ; while CES-D answers are heavily skewed toward low stress, the BJSQ responses are distributed more evenly across all four stress levels. This suggests that the BJSQ is better at capturing varying degrees of job stress compared to the depression-focused CES-D.

This table presents a statistical comparison of specific stress-related symptoms between two groups of participants, categorized by their urinary neurotransmitter levels as either High or Low. The authors list the average scores for various survey questions, such as feeling tired or experiencing joint pains, alongside the sample size and confidence intervals for each group.

By calculating the difference in averages and providing p-values, the visual highlights which specific psychological or physical complaints show statistically significant variation depending on the biological marker measured. Urinary dopamine responded strongly to feelings of dissatisfaction and physical fatigue.

Homovanillic acid levels were linked to poor working environments, sleep issues, and social isolation. When comparing the high and low stress groups, dopamine levels were significantly lower in the stressed group. Similarly, homovanillic acid, a metabolite of dopamine, also showed a significant drop in the high-stress group.

Figure 3 compares urinary neurotransmitter levels between high and low stress groups, revealing statistically significant differences for dopamine and homovanillic acid. To synthesize these findings into a single metric, the authors developed a stress index using a linear combination of all six markers with optimized weight factors.

The bottom panel demonstrates that this composite index successfully distinguishes between the two groups in both training and test sets, validating its potential as a robust biomarker for stress severity. The authors created a combined 'stress index' by mathematically weighting the six neurotransmitters together.

Dopamine and homovanillic acid had the highest weights in this formula, supporting their role as key markers. This index successfully distinguished between high and low stress groups in both training and testing sets. The study concludes that different neurotransmitters react to different types of stress, such as mood, appetite, or environment.

Because dopamine and homovanillic acid respond to overall stress severity, the combined index is a promising diagnostic tool. The authors prove that lower levels of dopamine and homovanillic acid in urine correlate with high job stress, offering a promising non-invasive tool for workplace health screening.